S9 Ep34: FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia
OncLive® On Air - Un pódcast de OncLive® On Air
Dr Kuykendall discusses the FDA approval of momelotinib in myelofibrosis with anemia, key data from the MOMENTUM trial, and how momelotinib alters the myelofibrosis treatment paradigm.
